These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 34253203)

  • 1. Low urinary iodine is a protective factor of central lymph node metastasis in papillary thyroid cancer: a cross-sectional study.
    Zeng Z; Li K; Wang X; Ouyang S; Zhang Z; Liu Z; Sun J; Ye X; Kang W; Yu J
    World J Surg Oncol; 2021 Jul; 19(1):208. PubMed ID: 34253203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High iodine intake and central lymph node metastasis risk of papillary thyroid cancer.
    Zhao H; Li H; Huang T
    J Trace Elem Med Biol; 2019 May; 53():16-21. PubMed ID: 30910201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High Iodine Nutrition May Be a Risk Factor for Cervical Lymph Node Metastasis in Papillary Thyroid Cancer Patients.
    Fan L; Tian Q; Xiu C; Wang F; Yuan Z; He Q; Guo L; Sun Q; Yang X; Miao S; Sun J; Sun D
    Ann Nutr Metab; 2021; 77(2):90-99. PubMed ID: 34289482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting factors of central lymph node metastasis and BRAF
    Zhou SL; Guo YP; Zhang L; Deng T; Xu ZG; Ding C; Sun WC; Zhao YW; Kong LF
    World J Surg Oncol; 2021 Jul; 19(1):211. PubMed ID: 34256769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of multifocality in papillary thyroid carcinoma.
    Feng JW; Qu Z; Qin AC; Pan H; Ye J; Jiang Y
    Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1820-1828. PubMed ID: 32732090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-risk factors for lymph node metastasis in contralateral central compartment in unilateral papillary thyroid carcinoma（cT1N0）.
    Zhou B; Qin J
    Eur J Surg Oncol; 2021 Apr; 47(4):882-887. PubMed ID: 33092967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors of central lymph node metastasis of papillary thyroid carcinoma: A single-center retrospective analysis of 3273 cases.
    Liu W; Cheng R; Su Y; Diao C; Qian J; Zhang J; Ma Y; Fan Y
    Medicine (Baltimore); 2017 Oct; 96(43):e8365. PubMed ID: 29069024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Patient and Tumor Characteristics on Central Lymph Node Metastasis in Papillary Thyroid Cancer: A Guide for Selective Node Dissection.
    Altiner S; Kozan R; Emral AC; Taneri F; Karamercan A
    Arch Iran Med; 2022 Nov; 25(11):730-736. PubMed ID: 37543897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for central lymph node metastasis in the cervical region in papillary thyroid carcinoma: a retrospective study.
    Li X; Zhang H; Zhou Y; Cheng R
    World J Surg Oncol; 2021 Apr; 19(1):138. PubMed ID: 33941214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and pathologic predictors of central lymph node metastasis in papillary thyroid microcarcinoma: a retrospective cohort study.
    Gui CY; Qiu SL; Peng ZH; Wang M
    J Endocrinol Invest; 2018 Apr; 41(4):403-409. PubMed ID: 28884301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between iodine nutrition and cervical lymph node metastasis of papillary thyroid microcarcinoma.
    Zhao H; Hu J; Cui L; Gong Y; Huang T
    Front Endocrinol (Lausanne); 2023; 14():1164069. PubMed ID: 37720525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analyze and compare the predictors of ipsilateral central lymph node metastasis in papillary thyroid carcinoma with cT1a and cT1b stage.
    Zhou B; Wei L; Qin J
    Asian J Surg; 2021 Nov; 44(11):1357-1362. PubMed ID: 33715963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultrasonic Feature Prediction of Large-Number Central Lymph Node Metastasis in Clinically Node-Negative Solitary Papillary Thyroid Carcinoma.
    Xiao W; Hu X; Zhang C; Qin X
    Endocr Res; 2023 Oct; 48(4):112-119. PubMed ID: 37606889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and ultrasonic risk factors for high-volume central lymph node metastasis in cN0 papillary thyroid microcarcinoma: A retrospective study and meta-analysis.
    Wang Z; Gui Z; Wang Z; Huang J; He L; Dong W; Zhang D; Zhang T; Shao L; Shi J; Wu P; Ji X; Zhang H; Sun W
    Clin Endocrinol (Oxf); 2023 Apr; 98(4):609-621. PubMed ID: 36263602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Impact of Coexistent Hashimoto's Thyroiditis on Central Compartment Lymph Node Metastasis in Papillary Thyroid Carcinoma.
    Liu Y; Lv H; Zhang S; Shi B; Sun Y
    Front Endocrinol (Lausanne); 2021; 12():772071. PubMed ID: 34867817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors associated with preferential lateral lymph node metastasis in papillary thyroid carcinoma.
    Shao L; Wang Z; Dong W; Sun W; Zhang H
    Cancer Med; 2023 Nov; 12(22):20670-20676. PubMed ID: 37905599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Value of Ki-67 Labeling Index in Central Lymph Node Metastasis and Survival of Papillary Thyroid Carcinoma: Evidence From the Clinical and Molecular Analyses.
    Lei Y; Zhao X; Feng Y; He D; Hu D; Min Y
    Cancer Control; 2023; 30():10732748231155701. PubMed ID: 36744396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of Risk Factors Associated With Central Lymph Node Metastasis in Papillary Thyroid Carcinoma With cT1N0 Stage.
    Zhao YZ; He NA; Ye XJ; Jin F; Li MX; Jiang X
    Front Endocrinol (Lausanne); 2022; 13():880911. PubMed ID: 35733781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A retrospective study of papillary thyroid carcinoma: Hashimoto's thyroiditis as a protective biomarker for lymph node metastasis.
    Wang Y; Zheng J; Hu X; Chang Q; Qiao Y; Yao X; Zhou X
    Eur J Surg Oncol; 2023 Mar; 49(3):560-567. PubMed ID: 36404253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction model of cervical lymph node metastasis based on clinicopathological characteristics of papillary thyroid carcinoma: a dual-center retrospective study.
    Liu W; Zhang D; Jiang H; Peng J; Xu F; Shu H; Su Z; Yi T; Lv Y
    Front Endocrinol (Lausanne); 2023; 14():1233929. PubMed ID: 37766691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.